Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
<p>Abstract</p> <p>Background</p> <p>Combination antiretroviral (AR) therapy continues to be the mainstay for HIV treatment. However, antiretroviral drug nonadherence can lead to the development of resistance and treatment failure. We have designed nanoparticles (NP) th...
Main Authors: | Sharma Akhilesh, Shibata Annemarie, Christensen Keith, Belgum Todd, Destache Christopher J, Dash Alekha |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-12-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/9/198 |
Similar Items
-
Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study
by: Subhra Mandal, et al.
Published: (2022-06-01) -
PLGA nanoparticles and microspheres for controlled drug delivery.
by: Gong, Tianxing.
Published: (2009) -
Drug-loaded PEG-PLGA nanoparticles for cancer treatment
by: Dan Zhang, et al.
Published: (2022-08-01) -
PLGA microspheres and nanoparticles drug delivery for ocular diseases
by: Tan, Chun Yi.
Published: (2010) -
Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres
by: Jimin Lee, et al.
Published: (2022-07-01)